These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4606968)

  • 21. Gene dosage studies with pleiotropic mutants of Serratia marcescens superactive in the synthesis of marcescin A and certain other exocellular proteins.
    Timmis K; Winkler U
    Mol Gen Genet; 1973 Aug; 124(3):207-17. PubMed ID: 4584941
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization and mode of action of a bacteriocin produced by a Bacteroides fragilis strain.
    Mossie KG; Jones DT; Robb FT; Woods DR
    Antimicrob Agents Chemother; 1979 Dec; 16(6):724-30. PubMed ID: 93876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriocins of Clostridium perfringens. 2. Studies on mode of action.
    Mahony DE; Butler ME; Lewis RG
    Can J Microbiol; 1971 Nov; 17(11):1435-42. PubMed ID: 4110002
    [No Abstract]   [Full Text] [Related]  

  • 24. E3 immunity substance. A protein from e3-colicinogenic cells that accounts for their immunity to colicin E3.
    Sidikaro J; Nomura M
    J Biol Chem; 1974 Jan; 249(2):445-53. PubMed ID: 4588567
    [No Abstract]   [Full Text] [Related]  

  • 25. A bacterial system useful in the isolation of RNA synthesis stimulating substances from phytohaemagglutinin or from sera.
    Fedorcsák I; Harms-Ringdahl M; Ehrenberg L
    Acta Microbiol Acad Sci Hung; 1973 Feb; 20(2):109-17. PubMed ID: 4590547
    [No Abstract]   [Full Text] [Related]  

  • 26. Properties and characteristics of a bacteriocin from Serratia marcescens.
    Foulds JD; Shemin D
    J Bacteriol; 1969 Sep; 99(3):655-60. PubMed ID: 4905530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colicins and other bacteriocins with established modes of action.
    Konisky J
    Annu Rev Microbiol; 1982; 36():125-44. PubMed ID: 6184011
    [No Abstract]   [Full Text] [Related]  

  • 28. Pleiotropic mutations in Serratia marcescens which increase the synthesis of certain exocellular proteins and the rate of spontaneous prophage induction.
    Winkler U; Timmis K
    Mol Gen Genet; 1973 Aug; 124(3):197-206. PubMed ID: 4584940
    [No Abstract]   [Full Text] [Related]  

  • 29. Products of defective lysogeny in Serratia marcescens SMG 38 and their activity against Escherichia coli and other Enterobacteria.
    Gratia JP
    J Gen Microbiol; 1989 Jan; 135(1):25-35. PubMed ID: 2674324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of Linnocuicina 819, a bacteriocin produced by Listeria innocua.
    Mollerach ME; Ogueta SB; De Torres RA
    Microbiologica; 1988 Jul; 11(3):219-24. PubMed ID: 3050374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excretion of the Escherichia coli alpha-haemolysin by Serratia marcescens.
    Palobart G; Juárez A; Tomas J; Regué M
    Microbios; 1991; 67(272-273):171-6. PubMed ID: 1779876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intracellular organisation of bacteriophage tail-like bacteriocins of group A in Serratia marcescens (author's transl)].
    Acker G
    Arch Microbiol; 1976 Dec; 111(1-2):175-83. PubMed ID: 797334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the mode of action of a bacteriocin produced by Bacillus stearothermophilus.
    Fikes JD; Crabtree BL; Barridge BD
    Can J Microbiol; 1983 Nov; 29(11):1576-82. PubMed ID: 6200195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and some properties of a heat-labile enterotoxin from escherichia coli.
    Söderlind O; Möllby R; Wadström T
    Zentralbl Bakteriol Orig A; 1974; 229(2):190-204. PubMed ID: 4155864
    [No Abstract]   [Full Text] [Related]  

  • 35. Production and properties of a bacteriocin from Myxococcus coralloides D.
    Muñoz J; Arias JM; Montoya E
    J Appl Bacteriol; 1984 Aug; 57(1):69-74. PubMed ID: 6436223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mode of action of megacin Cx on Bacillus megaterium KM].
    Durner K
    Z Allg Mikrobiol; 1970; 10(6):373-82. PubMed ID: 4991989
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inhibition of RNA synthesis in bacteria with strong control (rel + ) by quinone antibiotics].
    Ogilvie A; Kersten H; Kersten W
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):739-40. PubMed ID: 4560659
    [No Abstract]   [Full Text] [Related]  

  • 38. Properties and characteristics of a bacteriocin-like substance produced by Propionibacterium acnes isolated from dental plaque.
    Paul GE; Booth SJ
    Can J Microbiol; 1988 Dec; 34(12):1344-7. PubMed ID: 3233559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antibiotic edeine. 8. The mode of action of edeine A and B.
    Borowski E; Chmara H
    Acta Microbiol Pol; 1968; 17(3):241-8. PubMed ID: 4177303
    [No Abstract]   [Full Text] [Related]  

  • 40. Nitrofurantoin prompts the stringent response in Bacillus subtilis.
    Lopez JM; Fortnagel P
    J Gen Microbiol; 1981 Oct; 126(2):491-6. PubMed ID: 6175725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.